Marksans Pharma Limited announced its Annual General Meeting (AGM) details, scheduled for August 27, 2026. The company reported a robust financial performance for the fiscal year ended March 31, 2026. Standalone revenue increased by 12.5% to ₹13,414.76 crore, with Profit After Tax (PAT) rising to ₹3,006.98 crore. On a consolidated basis, revenue grew by 12.5% to ₹29,509.38 crore, and PAT reached ₹4,200.64 crore, demonstrating strong year-on-year growth across its operations.
Annual General Meeting and Financial Highlights
Marksans Pharma Limited has announced that its Thirty-Fourth (34th) Annual General Meeting (AGM) will be held on Thursday, August 27, 2026, at 11:00 AM through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also presented its financial results for the fiscal year ended March 31, 2026, highlighting significant growth.
Standalone Financial Performance
On a standalone basis, Marksans Pharma achieved a turnover of ₹13,414.76 crore for FY 2025-26, marking a 12.5% increase from the previous year’s ₹11,743.74 crore. The company’s net profit for the year stood at ₹3,006.98 crore, a substantial increase compared to ₹1,882.72 crore in the prior year.
Consolidated Financial Performance
On a consolidated basis, the company reported a turnover of ₹29,509.38 crore for FY 2025-26, an increase of 12.5% over the previous year’s ₹26,228.45 crore. The consolidated Profit After Tax (PAT) was ₹4,200.64 crore, up from ₹3,826.19 crore in the previous year. This strong performance was driven by growth in key markets, including a 24% year-on-year growth in the US and North America formulation business, and a 20% growth in the Australia and New Zealand formulation business.
Dividend Declaration
The Board of Directors has recommended a final dividend of ₹0.90/- (90%) per equity share of face value ₹1/- each for the financial year ended March 31, 2026, subject to shareholder approval at the AGM. The total cash outflow for the dividend payment is estimated at ₹407.85 crore.
E-Voting and AGM Participation
In compliance with regulatory circulars, the AGM will be conducted entirely through VC/OAVM. Physical attendance of members is dispensed with. Members can cast their votes electronically through remote e-voting from August 24, 2026, 09:00 A.M. to August 26, 2026, 05:00 P.M. E-voting will also be available during the AGM. Detailed instructions for e-voting and joining the virtual meeting are provided in the Notice.
Source: BSE
